At Fed. Circ., Novartis Rips Amgen's 'Patent Estate'
Novartis' generic drugmaking arm has told the Federal Circuit that a New Jersey federal judge got it wrong when he allowed Amgen to use an old, expired patent to generate "a patent estate" that would extend the American...To view the full article, register now.
Already a subscriber? Click here to view full article